BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3541758)

  • 1. [Value of cutaneous immunofluorescence in the etiological diagnosis of a disease with antinuclear antibodies].
    Lévêque E; Dréno B; Planchon B; Bureau B; Litoux P; Barrière H
    Ann Dermatol Venereol; 1986; 113(8):655-64. PubMed ID: 3541758
    [No Abstract]   [Full Text] [Related]  

  • 2. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors].
    Nebe H
    Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical manifestations and laboratory data of subacute cutaneous lupus erythematosus.
    Molad Y; Weinberger A; David M; Garty B; Wysenbeek AJ; Pinkhas J
    Isr J Med Sci; 1987 Apr; 23(4):278-80. PubMed ID: 3305416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fixation in vivo of antinuclear antibodies].
    Guillet G; Fizet D; Claudy A; Thivolet J
    Nouv Presse Med; 1979 Mar; 8(11):869. PubMed ID: 377217
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B; Lutowiecka-Wranicz A; Sysa-Jedrzejowska A; Torzecka D; Waszczykowska E
    Przegl Dermatol; 1990; 77(5):332-5. PubMed ID: 2125351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antinuclear antibodies in dermatology.
    Heffernan MP; Do JH; Mehta J
    Semin Cutan Med Surg; 2001 Mar; 20(1):2-13. PubMed ID: 11308133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of antibody to C5b-9 in the subclassification of lupus erythematosus.
    Magro CM; Crowson AN; Harrist TJ
    Br J Dermatol; 1996 May; 134(5):855-62. PubMed ID: 8736325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear antibodies and patterns of nuclear immunofluorescence in systemic lupus erythmatosus and other collagen vascular diseases.
    Bhuyan UN; Malaviya AN
    Indian J Med Res; 1976 Jun; 64(6):895-902. PubMed ID: 789235
    [No Abstract]   [Full Text] [Related]  

  • 9. A characteristic cutaneous direct immunofluorescent pattern associated with Ro(SS-A) antibodies in subacute cutaneous lupus erythematosus.
    Valeski JE; Kumar V; Forman AB; Beutner EH; Chorzelski TP
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 1):194-8. PubMed ID: 1430355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antinuclear antibody: significance of fluorescence patterns].
    Habermann F; de Franco MF
    Rev Hosp Clin Fac Med Sao Paulo; 1981 Jun; 36(3):123-7. PubMed ID: 7034129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Differentiation with immunofluorescence of complement fixing and non-fixing antinuclear factors in patients with and without disseminated lupus erythematosus].
    Peltier AP
    Pathol Biol; 1968 Apr; 16(7):439-44. PubMed ID: 4882383
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antinuclear antibodies in disseminated lupus erythematosus and other connective tissue diseases].
    Velasco M; Losada M; Losada A; Ramirez G
    Rev Med Chil; 1968 Aug; 96(8):517-21. PubMed ID: 4915546
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anticentromere antibodies. Diagnostic and prognostic value].
    Meyer O; Haïm T
    Nouv Presse Med; 1982 Oct; 11(39):2891-4. PubMed ID: 6755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Crithidia luciliae and Farr assays for the detection of systemic lupus erythematosus.
    Burdash NM; Teti G; Papadopoulos V
    Ann Clin Lab Sci; 1983; 13(1):49-54. PubMed ID: 6340594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study of antinuclear autoantibodies by immunofluorescence technic in collagen diseases].
    Fontaine J; Panisset LC
    Union Med Can; 1969 Aug; 98(8):1274-83. PubMed ID: 4919613
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous immunofluorescence.
    Weigand DA
    Med Clin North Am; 1989 Sep; 73(5):1263-74. PubMed ID: 2671545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunofluorescent "band" test for lupus erythematosus. II. Employing skin lesions.
    Burnham TK; Neblett TR; Fine G
    Arch Dermatol; 1970 Jul; 102(1):42-50. PubMed ID: 4925010
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical usefulness of detection of serum antinuclear antibodies by the immunofluorescence method].
    Wranicz A
    Przegl Dermatol; 1971; 58(6):685-90. PubMed ID: 4945137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.